Pharmacokinetics of furosemide in thoroughbred horses subjected to supramaximal treadmill exercise with and without controlled access to water

• Published in: BMC veterinary research Vol. 15; no. 1; pp. 275 - 10
• Main Authors: Villarino, N F, Lopez, C M, Sams, R A, Bayly, W M
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.08.2019; BioMed Central; BMC
• Subjects: Analysis; Animals; Area Under Curve; Chromatography; Controlled water intake; Diuretics; Diuretics - blood; Diuretics - pharmacokinetics; Dosage and administration; Drug therapy; Exercise-induced pulmonary hemorrhage; Female; Furosemide; Furosemide - blood; Furosemide - pharmacokinetics; Hemorrhage; Horse racing; Horses; Horses - blood; Liquid chromatography; Male; Pharmacokinetics; Physical Conditioning, Animal; Thoroughbred horses; Training; Water; Water-Electrolyte Balance; United States; Controlled water intake; Diuretics; Horses; Exercise-induced pulmonary hemorrhage; Pharmacokinetics; Furosemide
• ISSN: 1746-6148; 1746-6148
• DOI: 10.1186/s12917-019-2017-3

The primary objective of this study was to assess the disposition of furosemide in Thoroughbred horses treated intravenously with 1 mg/kg of furosemide 4 and 24 h before supramaximal treadmill exercise without and with controlled access to water, respectively. Another objective was to determine whether furosemide was detectable in the plasma of horses after exposure to supramaximal treadmill exercise. Thoroughbred horses (n = 4-6) were administered single intravenous doses of 1 mg/kg of furosemide at 4 and 24 h before supramaximal exercise on a high-speed treadmill, with controlled and free access to water, respectively. Plasma furosemide concentrations were determined using liquid chromatography. Furosemide was detected in all the horses, regardless of whether they were treated 24 h or 4 h before excersice. In both treatment sequence groups of 2 horses, the concentration time profiles of furosemide during the first 4 h after its administration were relatively similar. The average maximum observed concentrations, AUC and AUC , of both groups of horses were not different (p > 0.05). There were no significant differences in systemic clearance based on the geometric mean (95% confidence interval) (409 (347-482) mL/h/kg) for 4 h and 320 (177-580) mL/h/kg) for 24 h) between horses that were exercised 4- and 24-h post-furosemide administration. The plasma concentration of furosemide in all the horses fell below the limit of quantification (25 ng/mL) within 12 h after drug administration. In the group treated 24 h before exercise, none of the horses had detectable furosemide at the time of supramaximal treadmill exercise. In the group treated 4 h before exercise, furosemide was detected 1 h before and 2 h after supramaximal treadmill exercise in 4/4 and 3/4 horses, respectively. The mean AUC of both groups of horses were not different (p > 0.05). Water restriction did not exert any apparent effect on the disposition of furosemide. It remains to be determined, however, whether the attained plasma concentration of furosemide in combination with other controlled water access protocols have any direct or indirect pharmacological effect that may affect the athletic performance of the horse.